Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists

Details for Australian Patent Application No. 2005229765 (hide)

Owner Albert Einstein College of Medicine of Yeshiva University, a Division of Yeahiva University

Inventors Shen, Ke-Fei; Crain, Stanley M.

Agent Shelston IP

Pub. Number AU-A-2005229765

Parent 782665

Filing date 8 November 2005

Wipo publication date 5 January 2006

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

22 December 2005 Complete Application Filed

5 January 2006 Application Open to Public Inspection

  Published as AU-A-2005229765

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229766-Alignment guide for a saw

2005229764-Pre-corrugated insulated cup